Nisa Investment Advisors
SAGE

Nisa Investment Advisors’s Sage Therapeutics SAGE Stock Holding History

Nisa Investment Advisors’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-962
Closed -$8.77K – 3072
2025
Q2 		$8.77K Sell
962
-173
-15% -$1.27K ﹤0.01% 2322
2025
Q1 		$9.02K Buy
1,135
+405
+55% +$2.96K ﹤0.01% 2125
2024
Q4 		$3.96K Sell
730
-10
-1% -$61 ﹤0.01% 2331
2024
Q3 		$5.34K Sell
740
-5,490
-88% -$50.3K ﹤0.01% 2213
2024
Q2 		$67.7K Sell
6,230
-12,885
-67% -$165K ﹤0.01% 1579
2024
Q1 		$358K Buy
19,115
+75
+0.4% +$1.73K ﹤0.01% 1181
2023
Q4 		$413K Buy
19,040
+18,490
+3,362% +$366K ﹤0.01% 1108
2023
Q3 		$11.3K Sell
550
-1,479
-73% -$42.7K ﹤0.01% 2149
2023
Q2 		$95.4K Buy
2,029
+540
+36% +$26.9K ﹤0.01% 1522
2023
Q1 		$62K Hold
1,489
– – ﹤0.01% 1644
2022
Q4 		$57K Sell
1,489
-140
-9% -$5.35K ﹤0.01% 1731
2022
Q3 		$61K Buy
1,629
+90
+6% +$3.48K ﹤0.01% 1671
2022
Q2 		$50K Buy
1,539
+1,450
+1,629% +$48.6K ﹤0.01% 1736
2022
Q1 		$3K Sell
89
-125
-58% -$4.7K ﹤0.01% 2334
2021
Q4 		$8K Sell
214
-121
-36% -$5.07K ﹤0.01% 2056
2021
Q3 		$15 Sell
335
-1,702
-84% -$78.1K ﹤0.01% 2149
2021
Q2 		$116 Sell
2,037
-900
-31% -$63.6K ﹤0.01% 1614
2021
Q1 		$220 Hold
2,937
– – ﹤0.01% 1455
2020
Q4 		$254K Buy
2,937
+1,912
+187% +$141K ﹤0.01% 1371
2020
Q3 		$63K Hold
1,025
– – ﹤0.01% 1713
2020
Q2 		$43K Sell
1,025
-3,730
-78% -$135K ﹤0.01% 1612
2020
Q1 		$137K Buy
4,755
+750
+19% +$43.4K ﹤0.01% 1284
2019
Q4 		$289K Sell
4,005
-12,760
-76% -$1.57M ﹤0.01% 1240
2019
Q3 		$2.35M Buy
16,765
+16,590
+9,480% +$2.78M 0.02% 580
2019
Q2 		$32K Hold
175
– – ﹤0.01% 1553
2019
Q1 		$28K Sell
175
-1,930
-92% -$279K ﹤0.01% 1584
2018
Q4 		$202K Hold
2,105
– – ﹤0.01% 1239
2018
Q3 		$297K Buy
2,105
+1,930
+1,103% +$298K ﹤0.01% 1232
2018
Q2 		$27K Sell
175
-225
-56% -$35.3K ﹤0.01% 1512
2018
Q1 		$64K Sell
400
-50
-11% -$8.49K ﹤0.01% 1401
2017
Q4 		$74K Buy
450
+40
+10% +$3.88K ﹤0.01% 1420
2017
Q3 		$26K Hold
410
– – ﹤0.01% 1484
2017
Q2 		$33K Hold
410
– – ﹤0.01% 1434
2017
Q1 		$29K Buy
410
+10
+3% +$586 ﹤0.01% 1472
2016
Q4 		$20K Buy
+400
New +$18.9K ﹤0.01% 1641

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Nisa Investment Advisors's SAGE Position: Q3 2025 in Review

Nisa Investment Advisors sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 962 shares — an estimated $8.77K sold.

Nisa Investment Advisors first reported a position in SAGE in Q4 2016 and held it in 35 quarters. The position peaked at $2.35M in Q3 2019. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • Nisa Investment Advisors reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Nisa Investment Advisors sold 962 Sage Therapeutics shares in Q3 2025, an estimated $8.77K.
  • Nisa Investment Advisors first reported a position in Sage Therapeutics in Q4 2016 and held it in 35 quarters.
  • Nisa Investment Advisors's Sage Therapeutics position peaked at $2.35M in Q3 2019.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on Nisa Investment Advisors's 13F filing for Q3 2025, filed 23 Oct 2025.